6505-01-550-3893 ( NDC00182-1039-01 , 3040 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-550-3893 | 6505 | 015503893 | IBUPROFEN TABLETS,USP | 3450 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| FEAT | SPECIAL FEATURES | IBUPROFEN 200MG TABLETS PG 100S |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | IBUPROFEN 200MG TABLETS 100S |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00182-1039-01 | 3V8D7 | A | 2 | 3 | 4 | ZZ | |
| 3040 | 89875 | A | 1 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00182-1039-01 | 3V8D7 | TEVA PHARMACEUTICALS USA INC. | A | A |
| 3040 | 89875 | DEFENSE LOGISTICS AGENCY | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 04/18/2 | P | 3004909125 | 3450 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DF | N | SF9---N | F | K | U/I CONTAINS 100 TT |
| DA | C2203X- | A | K | U/I CONTAINS 100 TT | |
| DS | N | I | K | U/I CONTAINS 100 TT | |
| DN | 9B----- | N | K | U/I CONTAINS 100 TT |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DF | SMS | L | 1 | PG | M | U | SF9---N | F | |
| DA | SMS | L | 1 | PG | M | U | C2203X- | A | |
| DS | SMS | L | 1 | PG | M | U | D | ||
| DN | SMS | L | 1 | PG | M | U | 9B----- | N |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 03 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|